• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Coexisting Anti-I/i Plus Anti Pr Cold Agglutinins in Individual Sera.

作者信息

Roelcke D, König AL, Seyfert UT, Pereira A

出版信息

Infusionsther Transfusionsmed. 2000 May;27(3):149-153. doi: 10.1159/000025260.

DOI:10.1159/000025260
PMID:10878484
Abstract

Background: Sera with high-titer cold agglutinins (CAs) of unclear or even of apparently definite specificity may contain mixtures of CAs with different specificities. The combination of anti-I plus anti-Sia-b1 CAs in sera of patients with Mycoplasma pneumoniae infections is well documented. No systematic studies on CA mixtures in sera of patients with other diagnoses are available. Material and Methods: Sera of 322 patients with high-titer CAs were exhaustively absorbed with sialidase-treated red blood cells (RBCs). By absorption, CAs against the sialidase-resistant I/i antigens are removed. If CAs reacting with untreated RBCs are left after absorption, they are directed against the sialidase- and protease-sensitive Pr(1,2,3) antigens or against the sialidase-labile but protease-resistant antigens of the Sia-I/b/Ib complex. If CA mixtures were found, specificities and isotypes of the CAs obtained by cold adsorption and warm elution were determined. Results: Three patients had mixtures of anti-i plus anti-Pr CAs, 2 patients had mixtures of anti-I plus anti-Pr CAs. Conclusion: The occurrence of CAs directed against biochemically different antigens in individual sera proves two autoimmune processes against the same cells (erythrocytes) in the same patient. One explanation for this constellation would be a postinfection cold agglutination in a patient with chronic CA disease. Copyright 2000 S. Karger GmbH, Freiburg

摘要

相似文献

1
Coexisting Anti-I/i Plus Anti Pr Cold Agglutinins in Individual Sera.
Infusionsther Transfusionsmed. 2000 May;27(3):149-153. doi: 10.1159/000025260.
2
Sia-b1 and I antigens recognized by Mycoplasma pneumoniae-induced human cold agglutinins.肺炎支原体诱导的人冷凝集素所识别的Sia-b1和I抗原。
Transfusion. 1991 Sep;31(7):627-30. doi: 10.1046/j.1537-2995.1991.31791368339.x.
3
CMV-induced anti-Sia-b1 cold agglutinin in an immunocompromised patient.一名免疫功能低下患者体内的巨细胞病毒诱导的抗唾液酸-b1冷凝集素
Beitr Infusionsther Transfusionsmed. 1997;34:180-4.
4
Structure of antigens recognized by cold agglutinins.冷凝集素所识别的抗原结构。
Beitr Infusionsther Transfusionsmed. 1996;33:7-12.
5
Autoimmune hemolytic anemia caused by IgG lambda-monotypic cold agglutinins of anti-Pr specificity after rubella infection.风疹感染后由抗-Pr特异性的IgG λ单型冷凝集素引起的自身免疫性溶血性贫血。
Transfusion. 2001 Apr;41(4):488-92. doi: 10.1046/j.1537-2995.2001.41040488.x.
6
Red cell destruction in cold agglutinin disease.冷凝集素病中的红细胞破坏
Infusionsther Transfusionsmed. 1994 Dec;21(6):410-5. doi: 10.1159/000223021.
7
Alpha 2,3-specific desialylation of human red cells: effect on the autoantigens of the Pr, Sa and Sia-l1, -b1, -lb1 series.人红细胞的α2,3特异性去唾液酸化:对Pr、Sa和Sia-l1、-b1、-lb1系列自身抗原的影响。
Vox Sang. 1998;74(2):109-12.
8
[Increase of post-infection cold agglutinins after infection with Mycoplasma pneumoniae, varicella-zoster and rubella virus].[肺炎支原体、水痘-带状疱疹病毒及风疹病毒感染后感染后冷凝集素的增加]
Beitr Infusionsther Transfusionsmed. 1994;32:197-9.
9
Coexisting anti-I and anti-F1/Gd cold agglutinins in infections by Mycoplasma pneumoniae.肺炎支原体感染中并存的抗-I及抗-F1/Gd冷凝集素
Vox Sang. 1988;55(3):176-80. doi: 10.1111/j.1423-0410.1988.tb05088.x.
10
IgA cold agglutinins recognize Pr and Sa antigens expressed on glycophorins.IgA 冷凝集素识别糖蛋白上表达的 Pr 和 Sa 抗原。
Transfusion. 1993 Jun;33(6):472-5. doi: 10.1046/j.1537-2995.1993.33693296808.x.

引用本文的文献

1
B-Cell Lymphoma Producing IgM Anti-B Antibody: A Case Report.产生IgM抗B抗体的B细胞淋巴瘤:一例报告
Front Med (Lausanne). 2022 May 16;9:904296. doi: 10.3389/fmed.2022.904296. eCollection 2022.